The following is a list of clinical trials addressing the disease of uterine fibroids and currently enrolling patients:

Uterine Fibroid Growth Study

The Fibroid Growth Study (FGS) is designed to investigate why some fibroids grow to become health problems while others do not. Funding is provided jointly by the National Institute of Environmental Health Sciences (NIEHS) and the National Center for Research on Minority Health and Health Disparities (NCMHD).

To participate in this study, you must be able to make 4 visits within a one-year time period to the University of North Carolina (UNC) Hospital in Chapel Hill, NC. For more information, call or email the UNC, or visit the following web site:

www.niehs.nih.gov/fibroids/home.htm

Contact:
Martha Turvey, RN
UNC Hospitals Office
Telephone: 919-966-5288
martha_turvey@med.unc.edu

Finding Genes for Uterine Fibroids

Volunteers Wanted: SISTERS WHO HAVE (OR HAVE HAD) FIBROIDS

The Center for Uterine Fibroids at Brigham and Women's Hospital seeks participants for a study to identify genes involved in uterine fibroid tumors. We are looking for families in which two sisters have (or have had) uterine fibroids.

Please join us in our efforts to search for the causes of uterine fibroids and help future generations of women. For more information, call or email the Center, or visit the following web site:

www.fibroids.net

Contact:
Brigham and Womens Hospital
75 Francis Street Boston, MA 02115
Toll Free: 1-800-722-5520 x 80081 (within the United States)
Telephone: 617-278-0081
fibroids@rics.bwh.harvard.edu

UAE Fibroid Registry

The Cardiovascular and Interventional Radiology Research and Education Foundation (CIRREF) and the Society for Interventional Radiology (SIR), in cooperation with the Duke Clinical Research Institute (DCRI), have established the Uterine Artery Embolization (UAE) Fibroid Registry for Outcomes Data (FIBROID). The purpose of the FIBROID Registry is to generate sufficient data to demonstrate the safety and efficacy of UAE for the treatment of fibroids and to assess the procedure’s durability, impact on fertility and quality-of-life.

Patient Inclusion/Exclusion Criteria:

Patients undergoing UAE for uterine fibroids at participating sites. Patients enrolled through a selected subset of approximately 25 high volume sites (core) will be consented for participation in a longitudinal follow-up sub-study.

For more information and a list of participating sites, visit the following website:

www.fibroidregistry.org